These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8706776)

  • 41. Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
    Puttonen J; Kantele S; Kivikko M; Häkkinen S; Harjola VP; Koskinen P; Pentikäinen PJ
    Clin Pharmacokinet; 2007; 46(3):235-46. PubMed ID: 17328582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quinine unbound concentration is the best marker for therapeutic drug monitoring.
    de Pablos-Martinez C; Porte L; Fraissinet F; Berry A; Séraissol P; Lavit M; Chatelut E; Concordet D; Gandia P
    Therapie; 2016 Oct; 71(5):487-489. PubMed ID: 27203159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly.
    Dyer JR; Davis TM; Giele C; Annus T; Garcia-Webb P; Robson J
    Br J Clin Pharmacol; 1994 Sep; 38(3):205-12. PubMed ID: 7826821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure.
    Duntas L; Wolf CF; Keck FS; Rosenthal J
    Clin Nephrol; 1992 Oct; 38(4):214-8. PubMed ID: 1424308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intrarectal administration of quinine: an early treatment for severe malaria in children?].
    Barennes H; Kailou D; Pussard E; Munjakazi JM; Fernan M; Sherouat H; Sanda A; Clavier F; Verdier F
    Sante; 2001; 11(3):145-53. PubMed ID: 11641075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of disposition parameters of quinidine and quinine in the rat.
    Watari N; Wakamatsu A; Kaneniwa N
    J Pharmacobiodyn; 1989 Oct; 12(10):608-15. PubMed ID: 2630631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of cigarette smoking on quinine pharmacokinetics in malaria.
    Pukrittayakamee S; Pitisuttithum P; Zhang H; Jantra A; Wanwimolruk S; White NJ
    Eur J Clin Pharmacol; 2002 Aug; 58(5):315-9. PubMed ID: 12185554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Food increases the bioavailability of mefloquine.
    Crevoisier C; Handschin J; Barré J; Roumenov D; Kleinbloesem C
    Eur J Clin Pharmacol; 1997; 53(2):135-9. PubMed ID: 9403285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations.
    Newton PN; Ward S; Angus BJ; Chierakul W; Dondorp A; Ruangveerayuth R; Silamut K; Teerapong P; Suputtamongkol Y; Looareesuwan S; White NJ
    Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):184-6. PubMed ID: 16289166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disposition of oral quinine in acute falciparum malaria.
    Supanaranond W; Davis TM; Pukrittayakamee S; Silamut K; Karbwang J; Molunto P; Chanond L; White NJ
    Eur J Clin Pharmacol; 1991; 40(1):49-52. PubMed ID: 2060545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of tinoridine after oral administration to healthy subjects and patients with renal failure.
    Delhotal B; Flouvat B; Potaux L
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):410-6. PubMed ID: 6605310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioavailability of sulphate and dihydrochloride salts of quinine.
    Sowunmi A; Salako LA; Ogunbona FA
    Afr J Med Med Sci; 1994 Sep; 23(3):275-8. PubMed ID: 7604754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of quinine in young and elderly subjects.
    Wanwimolruk S; Chalcroft S; Coville PF; Campbell AJ
    Trans R Soc Trop Med Hyg; 1991; 85(6):714-7. PubMed ID: 1801332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of quinine, quinidine and Cinchonine when given as combination.
    Karbwang J; Bunnag D; Harinasuta T; Chittamas S; Berth J; Druilhe P
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):773-6. PubMed ID: 1298088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.